Lantheus
Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of
Lantheus Medical Imaging, Inc. (“LMI”), today announced that it will
host a conference call at 4:30 p.m. ET on Tuesday, May 3, 2016, to
discuss its financial and operating results for the first quarter of
2016.
To access the live conference call via telephone, please dial
1-866-498-8390 (U.S. callers) or 1-678-509-7599 (international callers)
and provide passcode 88571392. A live audio webcast of the call also
will be available on the homepage of the Company’s website at www.lantheus.com.
A replay of the telephone conference call and audio webcast will be
available from approximately 8:30 p.m. ET on May 3, 2016 through
midnight on May 17, 2016. To access a replay of the conference call,
dial 1-855-859-2056 (U.S. callers) or 1-404-537-3406 (international
callers), and provide passcode 88571392.
About Lantheus Holdings, Inc. and Lantheus Medical Imaging, Inc.
Lantheus Holdings, Inc. is the parent company of Lantheus Medical
Imaging, Inc., which is a global leader in the development, manufacture
and commercialization of innovative diagnostic imaging agents and
products. LMI provides a broad portfolio of products, which are
primarily used for the diagnosis of cardiovascular diseases. LMI’s key
products include the echocardiography contrast agent DEFINITY®
Vial for (Perflutren Lipid Microsphere) Injectable Suspension; TechneLite®
(Technetium Tc99m Generator), a technetium-based generator that provides
the essential medical isotope used in nuclear medicine procedures; and
Xenon (Xenon Xe 133 Gas), an inhaled radiopharmaceutical imaging agent
used to evaluate pulmonary function and for imaging the lungs. The
Company is headquartered in North Billerica, Massachusetts with offices
in Puerto Rico, Canada and Australia. For more information, visit www.lantheus.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160419006567/en/
Copyright Business Wire 2016